To all Trade Waste Licensees and Registrants: Please be aware that on Sunday, May 5, 2024, New York City will host its annual NYC Five Boro Bike Tour and there will be resulting temporary street closures across the five boroughs at the discretion of the NYPD.
A plan and a timeline for revocation of benefits under section 421-a of the real property tax law for each designated building for which such department received, during the reporting period from the department of housing preservation, pursuant to chapters 15 and 16 of title 26 of the code
Summary completions from DCAS provided trainings towards compliance for material trainings. These trainings relate to EEO, and Diversity and Inclusion for NYC employees.
The fact sheet provides count data for domestic violence homicides, calls to the NYC domestic violence hotline, counts for client visits to the NYC Family Justice Centers, visits to NYC HOPE resource directory online, the number of trainings and outreach events and contracted work.
Annual fair and effective affirmative employment plan to provide equal employment opportunity for minority group members and women who are employed by (or who seek employment with) the agency.
The 2024 Citywide Diabetes Reduction Plan, pursuant to Local Law 52 of 2023, describes the NYC Health Department's role in addressing diabetes inequalities and the proposed place-based strategies to reduce diabetes.
To All BIC Licensees:
On a quarterly basis, you must submit to the Commission a customer register that includes all customers located in New York City.
• Customer data for the period January 1, 2024 through March 31, 2024 is due by April 30, 2024.
Pursuant to Local Laws 60 and 64 of 2017, the EJNYC Report studies environmental burdens affecting communities of color and low-income communities and disparities in environmental benefits. The report also looks at how City processes meaningfully involve key stakeholders.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.